PURPOSE: Radical cystectomy (RC) can be associated with significant blood loss, whereas many patients are presenting with anemia preoperatively. To date, there is a lack of data addressing the impact of preoperative anemia (PA) on survival of patients undergoing RC for urothelial carcinoma of the bladder (UCB). METHODS: This retrospective multicenter study includes 684 patients with UCB undergoing RC with pelvic lymph node dissection. The median follow-up was 50 (IQR 29,78) months. Anemia was defined in line with the WHO classification (hemoglobin (Hb): male ≤13 g/dL, female ≤12 g/dL) and based on contemporary gender- and age-adjusted classification (Hb: white male aged <60 years: ≤13.7 g/dL; ≥60 years: ≤13.2 g/dL; white female of all ages ≤12.2 g/dL). Univariable and multivariable Cox regression analyses were used to assess the effects of PA on oncological outcomes. RESULTS: A total of 269 (39.3 %) and 302 (44.2 %) patients were anemic according to the WHO classification versus contemporary classification. Age, increased ECOG performance status, advanced tumor stages, lymph node metastasis, positive surgical margin and anemia were associated with disease recurrence (DR), cancer-specific mortality (CSM) and all-cause mortality (ACM). In multivariable analysis, anemia was an independent predictor of DR, CSM and ACM (WHO and/or contemporary classification). Blood transfusion was significantly associated with ACM in both classifications of anemia. CONCLUSIONS: PA is significantly associated with worse oncological outcome in patients undergoing RC. Based on the additional unfavorable influence of blood transfusion, this emphasizes the importance of early diagnosis and correction of anemia and implementation of alternative methods of blood volume management.
PURPOSE: Radical cystectomy (RC) can be associated with significant blood loss, whereas many patients are presenting with anemia preoperatively. To date, there is a lack of data addressing the impact of preoperative anemia (PA) on survival of patients undergoing RC for urothelial carcinoma of the bladder (UCB). METHODS: This retrospective multicenter study includes 684 patients with UCB undergoing RC with pelvic lymph node dissection. The median follow-up was 50 (IQR 29,78) months. Anemia was defined in line with the WHO classification (hemoglobin (Hb): male ≤13 g/dL, female ≤12 g/dL) and based on contemporary gender- and age-adjusted classification (Hb: white male aged <60 years: ≤13.7 g/dL; ≥60 years: ≤13.2 g/dL; white female of all ages ≤12.2 g/dL). Univariable and multivariable Cox regression analyses were used to assess the effects of PA on oncological outcomes. RESULTS: A total of 269 (39.3 %) and 302 (44.2 %) patients were anemic according to the WHO classification versus contemporary classification. Age, increased ECOG performance status, advanced tumor stages, lymph node metastasis, positive surgical margin and anemia were associated with disease recurrence (DR), cancer-specific mortality (CSM) and all-cause mortality (ACM). In multivariable analysis, anemia was an independent predictor of DR, CSM and ACM (WHO and/or contemporary classification). Blood transfusion was significantly associated with ACM in both classifications of anemia. CONCLUSIONS:PA is significantly associated with worse oncological outcome in patients undergoing RC. Based on the additional unfavorable influence of blood transfusion, this emphasizes the importance of early diagnosis and correction of anemia and implementation of alternative methods of blood volume management.
Authors: Stefan W Leichtle; Nicolas J Mouawad; Richard Lampman; Bonita Singal; Robert K Cleary Journal: J Am Coll Surg Date: 2011-02 Impact factor: 6.113
Authors: Roman Mayr; Matthias May; Thomas Martini; Michele Lodde; Armin Pycha; Evi Comploj; Wolf F Wieland; Stefan Denzinger; Wolfgang Otto; Maximilian Burger; Hans-Martin Fritsche Journal: BJU Int Date: 2012-02-07 Impact factor: 5.588
Authors: M Gierth; A Aziz; H M Fritsche; M Burger; W Otto; F Zeman; M T Pawlik; E Hansen; M May; S Denzinger Journal: World J Urol Date: 2014-02-08 Impact factor: 4.226
Authors: Maximilian Burger; James W F Catto; Guido Dalbagni; H Barton Grossman; Harry Herr; Pierre Karakiewicz; Wassim Kassouf; Lambertus A Kiemeney; Carlo La Vecchia; Shahrokh Shariat; Yair Lotan Journal: Eur Urol Date: 2012-07-25 Impact factor: 20.096
Authors: G R DeFoe; C S Ross; E M Olmstead; S D Surgenor; M P Fillinger; R C Groom; R J Forest; J W Pieroni; C S Warren; M E Bogosian; C F Krumholz; C Clark; R A Clough; P W Weldner; S J Lahey; B J Leavitt; C A Marrin; D C Charlesworth; P Marshall; G T O'Connor Journal: Ann Thorac Surg Date: 2001-03 Impact factor: 4.330
Authors: Arnulf Stenzl; Nigel C Cowan; Maria De Santis; Markus A Kuczyk; Axel S Merseburger; Maria José Ribal; Amir Sherif; J Alfred Witjes Journal: Eur Urol Date: 2011-03-23 Impact factor: 20.096
Authors: Todd M Morgan; Daniel A Barocas; Sam S Chang; Sharon E Phillips; Shady Salem; Peter E Clark; David F Penson; Joseph A Smith; Michael S Cookson Journal: Urol Oncol Date: 2011-09-09 Impact factor: 3.498
Authors: Gunnar Birgegård; Matti S Aapro; Carsten Bokemeyer; Mario Dicato; Peter Drings; Javier Hornedo; Maciej Krzakowski; Heinz Ludwig; Sergio Pecorelli; Hans Schmoll; Maurice Schneider; Dirk Schrijvers; Daniel Shasha; Simon Van Belle Journal: Oncology Date: 2005 Impact factor: 2.935
Authors: Tina Schubert; Tilman Todenhöfer; Johannes Mischinger; Christian Schwentner; Markus Renninger; Arnulf Stenzl; Georgios Gakis Journal: World J Urol Date: 2015-09-29 Impact factor: 4.226
Authors: Jung Ki Jo; Seong Jin Jeong; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee; Jong Jin Oh Journal: Int Urol Nephrol Date: 2016-01-25 Impact factor: 2.370
Authors: Bimal Bhindi; Thomas Hermanns; Yanliang Wei; Julie Yu; Patrick O Richard; Marian S Wettstein; Arnoud Templeton; Kathy Li; Srikala S Sridhar; Michael A S Jewett; Neil E Fleshner; Alexandre R Zlotta; Girish S Kulkarni Journal: Br J Cancer Date: 2015-12-10 Impact factor: 7.640